Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vaccines in Multiple Sclerosis.
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Multiple sclerosis or neurological manifestations of Celiac disease.
High nationwide incidence of multiple sclerosis in sweden.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Neuropsychological, balance and mobility risk factors for falls in people with multiple sclerosis: a prospective cohort study.
In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
The experiences of support persons of people newly diagnosed with multiple sclerosis: an interpretative phenomenological study.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Multiple sclerosis and related disorders: evolving pathophysiologic insights.
Metabolomics in multiple sclerosis.
Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome.
Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment.
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.
Deletion of jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo.
Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology.
Multiple Sclerosis.
A Limited Form of Neuromyelitis Optica With a Lesion of the Fourth Nerve Nucleus.
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: "A rare combination of two uncommon disorders".
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Pages
« first
‹ previous
…
708
709
710
711
712
713
714
715
716
…
next ›
last »